v3.26.3
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Statement of Cash Flows [Abstract]    
Net Loss $ (15,560,223) $ (9,050,423)
Adjustments to reconcile net loss to net cash used in operations:    
Depreciation 3,606 2,675
Stock based compensation 390,716 589,730
Non-cash expense for issuance of restricted stock grant awards 83,999 0
Amortization of debt issuance costs 174,022 174,022
Capital issued for interest expense 1,520,833 1,516,667
Accretion expense 227,647 225,413
Settlement of asset retirement obligations (120,000) (120,000)
Loss from change in fair value of derivative liability 4,868,289 435,824
Loss from change in fair value of warrant liability 833,905 0
Deferred tax expense 4,853 19,249
Effect of changes in operating working capital items:    
Change in other assets (15,753) 0
Change in prepaid expenses 139,748 (36,606)
Change in reclamation bonds accounts 37,395 0
Change in accounts payable 127,141 (23,835)
Cash used in operating activities (7,283,822) (6,267,284)
Cash flows from investing activities:    
Purchase of mineral properties (50,000) (150,000)
Purchase of equipment 0 (11,483)
Cash used in investing activities (50,000) (161,483)
Cash flows from financing activities    
Capital issued for financing, net of share issuance costs 13,914,027 2,356,709
Proceeds from warrant private placement 2,000,000 0
Cash provided by financing activities 15,914,027 2,356,709
Change in cash during period 8,580,205 (4,072,058)
Cash at beginning of period 1,351,001 5,423,059
Cash at end of period $ 9,931,206 $ 1,351,001